News

In February 2021 Henriette Svarre Nielsen stepped into ReproUnion’s Executive Board. Since 2018 she has been part of ReproUnion’s Challenge 2 and worked alongside colleagues in Greater Copenhagen to launch the ReproUnion Biobank & Infertility Cohort (RUBIC).

EU/Interreg, Region Hovedstaden, Region Skåne and Ferring are supporting ReproUnion with EUR 2.3 million to carry out additional reproductive research, which will assess the impact of the COVID-19 virus on fertility, pregnancy, and fetus.

Fostering the next generation of researchers is vital to meet the future demands of managing and preventing infertility problems. Here we feature Selma Kløve Landersø and Pernille Udesen, who were among the first to virtually defend their ReproUnion supported-PhDs during the COVID-19 pandemic.

The first week of November marked the European Fertility week 2020, calling for European policymakers to ensure equal, fair and safe access to fertility treatments.

The new resources from the ReproUnion Biobank & Infertility Cohort (RUBIC) will enhance the dialogue with couples interested in the research project.

In his final State of the Union Address in 2016, President Obama called on then Vice President Biden to lead a new, national “Moonshot” initiative to eliminate cancer as we know it. The European Cancer Moonshot Lund Center was established and ReproUnion board member, Professor Johan Malm, had the pleasure to meet Joe Biden.

“We need deeper insights about the biology associated with ovarian ageing to provide future strategies for prevention and/or treatments of age-related female infertility. Ultimately, a clinical biomarker for ovarian ageing would enable women to better plan the time for pregnancy – according to their own life preferences in combination with their own biology,” said Kristina Wendelboe Olsen, who defended her PhD on th25 September 2020.

ReproUnion’s challenge 3 is building detailed knowledge of ovarian function towards the ultimate aim of creating a human artificial ovary within a ten-year period. This includes methods to mature oocytes outside the body (IVM), which is contributing to set the agenda worldwide

460 women from Denmark, Sweden and Spain participated in the study, which shows similar ongoing pregnancy rates after frozen compared to fresh embryo transfer.

On the 5th of July, the European Society of Human Reproduction and Embryology (ESHRE) kicked off its 36th Annual Meeting as a virtual conference with 12,191 participants from all over the world.